Decreased PTV margin with hypofractionated radiotherapy for prostate cancer
This article has no abstract so we have provided the first paragraph of the full text.
The standard dose of radiotherapy used to treat prostate cancer is 
70 Gy. Studies suggest that fractions at a higher dose could increase biochemical control rates, especially in patients with high-risk or medium-risk disease. In addition, HYPOFRACTIONATED RADIOTHERAPY could result in more efficient killing of cancer cells. Without high-precision radiotherapy, however, toxicities could be increased significantly.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.